Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Investigation
|
November 5, 1999
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
W M Macfarlane, T M Frayling, S Ellard, et al.
Journal of Inherited Metabolic Disease
|
August 16, 2008
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome
G Engelmann, J Meyburg, N Shahbek, et al.
Diabetologia
|
April 15, 2005
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection
E R Pearson, S Pruhova, C J Tack, et al.
Diabetes
|
December 2, 1999
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes
T M Frayling, M Walker, M I McCarthy, et al.
Diabetologia
|
September 11, 2007
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young
S Ellard, K Thomas, E L Edghill, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 11, 2015
Expanding the Clinical Spectrum Associated With GLIS3 Mutations
P Dimitri, A M Habeb, F Gurbuz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 6, 2019
Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population
H Yaghootkar, F Abbasi, N Ghaemi, et al.
Diabetologia
|
November 1, 2012
Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype
S E Flanagan, D J G Mackay, S A W Greeley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Investigation
|
November 5, 1999
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
W M Macfarlane, T M Frayling, S Ellard, et al.
Journal of Inherited Metabolic Disease
|
August 16, 2008
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome
G Engelmann, J Meyburg, N Shahbek, et al.
Diabetologia
|
April 15, 2005
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection
E R Pearson, S Pruhova, C J Tack, et al.
Diabetes
|
December 2, 1999
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes
T M Frayling, M Walker, M I McCarthy, et al.
Diabetologia
|
September 11, 2007
Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young
S Ellard, K Thomas, E L Edghill, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 11, 2015
Expanding the Clinical Spectrum Associated With GLIS3 Mutations
P Dimitri, A M Habeb, F Gurbuz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 6, 2019
Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population
H Yaghootkar, F Abbasi, N Ghaemi, et al.
Diabetologia
|
November 1, 2012
Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype
S E Flanagan, D J G Mackay, S A W Greeley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2018
Safety and dose modification for patients receiving niraparib
J S Berek, U A Matulonis, U Peen, et al.
Page
of 15